AI for fairer clinical decisions

Abstract

<p>Artificial intelligence (AI) has the potential to transform early diagnosis and subsequent treatment of neurological conditions, such as Parkinson’s disease. Early diagnosis means quicker access to vital care and support that could improve an individual’s quality of life and disease progression. But the applications of AI do not stop there – AI is also helping researchers to better understand the causes of Parkinson’s by assessing the changes in the brain at the initial stages of the disease. These early insights could be the key to developing new and better treatments.</p> <p>At Skein, we are working on an AI tool to assist clinicians with the decision-making for Parkinson’s. This can be informed by patient data, but unfortunately many datasets are not representative of the population. Improving the quality and diversity of the data will provide the greatest insights for the medical community, allowing for a broader identification of a range of factors, patterns or correlations, which would ultimately improve the accuracy and reliability of diagnosis and prognosis.</p>

Ähnliche Arbeiten